These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1948 related articles for article (PubMed ID: 17962520)

  • 1. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor.
    Cherezov V; Rosenbaum DM; Hanson MA; Rasmussen SG; Thian FS; Kobilka TS; Choi HJ; Kuhn P; Weis WI; Kobilka BK; Stevens RC
    Science; 2007 Nov; 318(5854):1258-65. PubMed ID: 17962520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function.
    Rosenbaum DM; Cherezov V; Hanson MA; Rasmussen SG; Thian FS; Kobilka TS; Choi HJ; Yao XJ; Weis WI; Stevens RC; Kobilka BK
    Science; 2007 Nov; 318(5854):1266-73. PubMed ID: 17962519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemistry. Signaling across the cell membrane.
    Ranganathan R
    Science; 2007 Nov; 318(5854):1253-4. PubMed ID: 18033872
    [No Abstract]   [Full Text] [Related]  

  • 4. Crystallization of G protein-coupled receptors.
    Salom D; Padayatti PS; Palczewski K
    Methods Cell Biol; 2013; 117():451-68. PubMed ID: 24143992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and function of an irreversible agonist-β(2) adrenoceptor complex.
    Rosenbaum DM; Zhang C; Lyons JA; Holl R; Aragao D; Arlow DH; Rasmussen SG; Choi HJ; Devree BT; Sunahara RK; Chae PS; Gellman SH; Dror RO; Shaw DE; Weis WI; Caffrey M; Gmeiner P; Kobilka BK
    Nature; 2011 Jan; 469(7329):236-40. PubMed ID: 21228876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal T4 lysozyme fusion facilitates crystallization of a G protein coupled receptor.
    Zou Y; Weis WI; Kobilka BK
    PLoS One; 2012; 7(10):e46039. PubMed ID: 23056231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor.
    Goetz A; Lanig H; Gmeiner P; Clark T
    J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor.
    Rasmussen SG; Choi HJ; Rosenbaum DM; Kobilka TS; Thian FS; Edwards PC; Burghammer M; Ratnala VR; Sanishvili R; Fischetti RF; Schertler GF; Weis WI; Kobilka BK
    Nature; 2007 Nov; 450(7168):383-7. PubMed ID: 17952055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying conformational changes of the beta(2) adrenoceptor that enable accurate prediction of ligand/receptor interactions and screening for GPCR modulators.
    Reynolds KA; Katritch V; Abagyan R
    J Comput Aided Mol Des; 2009 May; 23(5):273-88. PubMed ID: 19148767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the applicability of GPCR homology models to computer-aided drug discovery: a comparison between in silico and crystal structures of the beta2-adrenergic receptor.
    Costanzi S
    J Med Chem; 2008 May; 51(10):2907-14. PubMed ID: 18442228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural features of β2 adrenergic receptor: crystal structures and beyond.
    Bang I; Choi HJ
    Mol Cells; 2015; 38(2):105-11. PubMed ID: 25537861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
    Huber T; Menon S; Sakmar TP
    Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FoldGPCR: structure prediction protocol for the transmembrane domain of G protein-coupled receptors from class A.
    Michino M; Chen J; Stevens RC; Brooks CL
    Proteins; 2010 Aug; 78(10):2189-201. PubMed ID: 20544957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystallizing thinking about the beta2-adrenergic receptor.
    Shukla AK; Sun JP; Lefkowitz RJ
    Mol Pharmacol; 2008 May; 73(5):1333-8. PubMed ID: 18239031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies.
    Yuzlenko O; Kieć-Kononowicz K
    J Comput Chem; 2009 Jan; 30(1):14-32. PubMed ID: 18496794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β
    Eddy MT; Didenko T; Stevens RC; Wüthrich K
    Structure; 2016 Dec; 24(12):2190-2197. PubMed ID: 27839952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes.
    Katritch V; Reynolds KA; Cherezov V; Hanson MA; Roth CB; Yeager M; Abagyan R
    J Mol Recognit; 2009; 22(4):307-18. PubMed ID: 19353579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into signaling from the beta2-adrenergic receptor structure.
    Audet M; Bouvier M
    Nat Chem Biol; 2008 Jul; 4(7):397-403. PubMed ID: 18560432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor.
    Bokoch MP; Zou Y; Rasmussen SG; Liu CW; Nygaard R; Rosenbaum DM; Fung JJ; Choi HJ; Thian FS; Kobilka TS; Puglisi JD; Weis WI; Pardo L; Prosser RS; Mueller L; Kobilka BK
    Nature; 2010 Jan; 463(7277):108-12. PubMed ID: 20054398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand entry and exit pathways in the beta2-adrenergic receptor.
    Wang T; Duan Y
    J Mol Biol; 2009 Oct; 392(4):1102-15. PubMed ID: 19665031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 98.